Telix Pharmaceuticals Ltd has released a press release.
Appendix 4C - June 2018 Quarter
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- TLX and JFE progress Japanese manufacturing partnership
- Prostate imaging regulatory update - FDA review of DMF
- Telix and Isologic conclude manufacturing agreement
- SEIF Grant Awarded for Advanced Biologics Manufacturing
- Telix and Osaka U receive funding for Alpha Nuclide Research
Later from Telix Pharmaceuticals
- Telix receives $55m Overseas Finding
- Telix JV Entity Extends Contract with Endocyte to Include EU
- Collaboration on Renal Cancer Imaging for Japanese market
- Telix files Ph III trial for Kidney Cancer Imaging in Europe
- Half Yearly Report and Accounts
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals